Intercept rallies ahead of conference, BofA defends lofty target

|About: Intercept Pharmaceuticals (ICPT)|By:, SA News Editor

Investors will be watching Intercept Pharmaceuticals (ICPT) closely today after a wild ride during the last four trading sessions.

The company is set to present at the JPMorgan Healthcare Conference at 10:30 ET. Here's TheStreet's Adam Feuerstein: "[It's] going to be an adventure."

Meanwhile, BofA's Rachel McMinn (who caused a stir by putting an $872 price target on the shares last week) is out in defense of the stock, which has fallen over the past two days.

Ultimately, McMinn thinks investors need to be patient, given OCA's potential.

ICPT +7% premarket